Targeting esophageal cancer with HDL nanoparticles: an imaging study - TARGET

Academic Medical Center0 个研究点目标入组 13 人开始时间: 2017年7月19日最近更新: 2018年7月23日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•-Adult patients (either gender) older than 18 years
•-Clinical diagnosis of primary esophageal cancer
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 13
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 13

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•-Any treatment that could interfere with the conduct or interpretation of the study in the opinion of the investigator
•-Any clinically relevant condition that could interfere with the conduct of the study in the opinion of the investigator
•-Standard contra-indications to PET, CT or MRI
•-Inability or unwilling to comply with protocol requirements, or deemed by the investigator to have a disorder that may compromise the ability to give informed consent and/or to comply with all required study procedures and visits

发起方

Academic Medical Center